Chikako Ohwada

1.4k total citations
63 papers, 691 citations indexed

About

Chikako Ohwada is a scholar working on Hematology, Neurology and Immunology. According to data from OpenAlex, Chikako Ohwada has authored 63 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 16 papers in Neurology and 12 papers in Immunology. Recurrent topics in Chikako Ohwada's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Chikako Ohwada is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Chikako Ohwada collaborates with scholars based in Japan, United States and Austria. Chikako Ohwada's co-authors include Chiaki Nakaseko, Masahiro Takeuchi, Emiko Sakaida, Yusuke Takeda, Naomi Shimizu, Tohru Iseki, Shokichi Tsukamoto, Miki Nishimura, Koutaro Yokote and Naoya Mimura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Chikako Ohwada

59 papers receiving 683 citations

Peers

Chikako Ohwada
Qin Huang United States
Sarah M. Larson United States
Dale Frank United States
Chikako Ohwada
Citations per year, relative to Chikako Ohwada Chikako Ohwada (= 1×) peers Eliana Miranda

Countries citing papers authored by Chikako Ohwada

Since Specialization
Citations

This map shows the geographic impact of Chikako Ohwada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikako Ohwada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikako Ohwada more than expected).

Fields of papers citing papers by Chikako Ohwada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chikako Ohwada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikako Ohwada. The network helps show where Chikako Ohwada may publish in the future.

Co-authorship network of co-authors of Chikako Ohwada

This figure shows the co-authorship network connecting the top 25 collaborators of Chikako Ohwada. A scholar is included among the top collaborators of Chikako Ohwada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chikako Ohwada. Chikako Ohwada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohwada, Chikako, Keita Kirito, Akane Tanaka, et al.. (2025). Successful autologous stem cell transplantation in a case of central nervous system relapse of diffuse large B-cell lymphoma with concurrent polycythemia vera. International Journal of Hematology. 122(5). 766–770.
2.
Tsukamoto, Shokichi, Yusuke Takeda, Chikako Ohwada, et al.. (2024). Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 120(4). 501–511. 1 indexed citations
3.
Ohwada, Chikako, Shingo Yamazaki, Katsuhiro Shono, et al.. (2021). Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation. International Journal of Hematology. 114(6). 664–673. 2 indexed citations
4.
Suzuki, Junya, Hajime Kasai, Jiro Terada, et al.. (2021). Bronchiolitis obliterans after stem cell transplantation for hematologic malignancies rescued by lung transplantation: A report of two cases. Respiratory Investigation. 59(4). 559–563. 3 indexed citations
5.
Tsukamoto, Shokichi, Miki Yamazaki, Yutaro Hino, et al.. (2021). Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease. SHILAP Revista de lepidopterología. 16. 100278–100278. 2 indexed citations
6.
Ohwada, Chikako, Yutaro Hino, Kensuke Kayamori, et al.. (2020). Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome. Bone Marrow Transplantation. 56(2). 517–520. 6 indexed citations
7.
Kikuchi, Taku, Takehiko Mori, Chikako Ohwada, et al.. (2020). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. International Journal of Hematology. 113(1). 128–133. 5 indexed citations
8.
Kurosawa, Saiko, Yasushi Onishi, Chikako Ohwada, et al.. (2020). Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan. Biology of Blood and Marrow Transplantation. 26(5). 949–955. 8 indexed citations
10.
Shimizu, Naomi, Tomoya Muto, Shokichi Tsukamoto, et al.. (2018). Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Annals of Hematology. 97(4). 655–662. 17 indexed citations
11.
Ohwada, Chikako, Emiko Sakaida, Tomoya Muto, et al.. (2018). Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 131(19). 2173–2176. 23 indexed citations
12.
Muto, Tomoya, Naoya Mimura, Shokichi Tsukamoto, et al.. (2018). Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma. International Journal of Hematology. 108(4). 452–455. 2 indexed citations
13.
Misawa, Sonoko, Yasunori Sato, K. Katayama, et al.. (2015). Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 5(11). e009157–e009157. 40 indexed citations
14.
Muto, Tomoya, Masahiro Takeuchi, Atsuko Yamazaki, et al.. (2015). Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia. International Journal of Hematology. 102(1). 86–92. 5 indexed citations
15.
Ebinuma, Hiroyuki, Isamu Fukamachi, Chikako Ohwada, et al.. (2014). Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma. Clinica Chimica Acta. 430. 48–54. 9 indexed citations
16.
Tanaka, Hiroaki, Shinichiro Hashimoto, Yusuke Takeda, et al.. (2014). Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status. International Journal of Hematology. 99(4). 513–518. 12 indexed citations
17.
Nakaseko, Chiaki, Masahiro Takeuchi, Chikako Ohwada, et al.. (2012). Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clinica Chimica Acta. 413(19-20). 1542–1548. 15 indexed citations
19.
Tsukamoto, Shokichi, Masahiro Takeuchi, Satomi Tanaka, et al.. (2011). Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy. International Journal of Hematology. 95(2). 204–208. 11 indexed citations
20.
Koizumi, Masayuki, Chiaki Nakaseko, Chikako Ohwada, et al.. (2007). Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone‐resistant myeloma cells. European Journal Of Haematology. 79(5). 382–391. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026